CHIR 99021, 25 mg

CHIR 99021, 25 mg

Contact us: [email protected]

CHIR-99021 (CT99021)

E1KS1263 2mg
EUR 390

CHIR-99021 (CT99021)

A3011-10 10 mg
EUR 205.2
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021)

A3011-100 100 mg
EUR 831.6
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021)

A3011-5 5 mg
EUR 157.2
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021)

A3011-5.1 10 mM (in 1mL DMSO)
EUR 199.2
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021)

A3011-S Evaluation Sample
EUR 97.2
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR 99021 trihydrochloride

B1199-5
EUR 352.8

CHIR 99021 trihydrochloride

B5779-10 10 mg
EUR 268.8

CHIR 99021 trihydrochloride

B5779-5 5 mg
EUR 174

CHIR-99021 (monohydrochloride)

HY-10182A 50mg
EUR 870

CHIR-99021 (trihydrochloride)

HY-10182B 50mg
EUR 870

CHIR-99021 (CT99021) HCl

A8396-10 10 mg
EUR 205.2
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021) HCl

A8396-100 100 mg
EUR 831.6
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021) HCl

A8396-5 5 mg
EUR 157.2
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021) HCl

A8396-5.1 10 mM (in 1mL DMSO)
EUR 170.4
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021) HCl

A8396-S Evaluation Sample
EUR 97.2
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR 99021, GSK-3 Inhibitor , HCl

BC213-005 5 mg
EUR 343.2

CHIR 99021, GSK-3 Inhibitor , HCl

BC213-025 25 mg
EUR 1016.4

CHIR 99021, GSK-3 Inhibitor , Free Base

BC212-002 2 mg
EUR 213.6

CHIR 99021, GSK-3 Inhibitor , Free Base

BC212-005 5 mg
EUR 318

CHIR 99021, GSK-3 Inhibitor , Free Base

BC212-010 10 mg
EUR 378

CHIR 99021, GSK-3 Inhibitor , Free Base

BC212-025 25 mg
EUR 472.8

CHIR 99021, GSK-3 Inhibitor , Free Base

BC212-100 100 mg
EUR 1064.4

CHIR-124

A8394-25 25 mg
EUR 408
Description: CHIR-124, a selective inhibitor, inhibits Chk1 with IC50 value of 0.3nM 2,000-fold more potently than Chk2 with IC50 value of 0.7?M.

CHIR-98014

A8395-25 25 mg
EUR 448.8
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1].

CHIR-090

B1852-25
EUR 810

Dovitinib (TKI-258, CHIR-258)

A2168-25 25 mg
EUR 268.8
Description: Dovitinib (TKI258, CHIR-258) is a multitargeted receptor tyrosine kinase inhibitor against FLT3, KIT, FGFR, VEGFR, PDGFR? and PDGFR? with IC50 of 1 nM, 2 nM, 8-9 nM, 8-13 nM , 210 nM and 27nM, respectively [1].

Cyanine3 azide, 25 mg

D1030 25 mg
EUR 379.2

Cyanine3 alkyne, 25 mg

D10B0 25 mg
EUR 379.2

Cyanine3 DBCO, 25 mg

D10F0 25 mg
EUR 379.2

Cyanine3.5 azide, 25 mg

D2030 25 mg
EUR 379.2

Cyanine5 azide, 25 mg

D3030 25 mg
EUR 379.2

Cyanine5 alkyne, 25 mg

D30B0 25 mg
EUR 379.2

Cyanine5 DBCO, 25 mg

D30F0 25 mg
EUR 379.2

Biotin alkyne, 25 mg

D37B0 25 mg
EUR 169.2

Cyanine5.5 azide, 25 mg

D4030 25 mg
EUR 379.2

PEP azide, 25 mg

D4530 25 mg
EUR 379.2

Cyanine7 azide, 25 mg

D5030 25 mg
EUR 379.2

Cyanine7 alkyne, 25 mg

D50B0 25 mg
EUR 379.2

Cyanine7 DBCO, 25 mg

D50F0 25 mg
EUR 379.2

Perylene azide, 25 mg

D5530 25 mg
EUR 379.2

Cyanine7.5 azide, 25 mg

D6030 25 mg
EUR 379.2

Cyanine7.5 alkyne, 25 mg

D60B0 25 mg
EUR 379.2

Cyanine5.5 alkyne, 25 mg

D70B0 25 mg
EUR 379.2

Cyanine5.5 DBCO, 25 mg

D70F0 25 mg
EUR 379.2

Cyanine5.5 hydrazide, 25 mg

47070 25 mg
EUR 379.2

Cyanine5.5 maleimide, 25 mg

47080 25 mg
EUR 379.2

Cyanine5.5 amine, 25 mg

470C0 25 mg
EUR 379.2

Cyanine7.5 tetrazine, 25 mg

460 25 mg
EUR 615.6

Cyanine7.5 hydrazide, 25 mg

46070 25 mg
EUR 379.2

Cyanine7.5 maleimide, 25 mg

46080 25 mg
EUR 379.2

Cyanine7.5 amine, 25 mg

460C0 25 mg
EUR 379.2

Cyanine7 tetrazine, 25 mg

450 25 mg
EUR 615.6

Cyanine7 hydrazide, 25 mg

45070 25 mg
EUR 379.2

Cyanine7 maleimide, 25 mg

45080 25 mg
EUR 379.2

Cyanine7 amine, 25 mg

450C0 25 mg
EUR 379.2

Cyanine5 tetrazine, 25 mg

430 25 mg
EUR 615.6

Cyanine5 hydrazide, 25 mg

43070 25 mg
EUR 379.2

Cyanine5 maleimide, 25 mg

43080 25 mg
EUR 379.2

Cyanine5 amine, 25 mg

430C0 25 mg
EUR 379.2

Pyrene hydrazide, 25 mg

43570 25 mg
EUR 379.2

Pyrene maleimide, 25 mg

43580 25 mg
EUR 379.2

Alkyne hydrazide, 25 mg

41770 25 mg
EUR 121.2

Alkyne maleimide, 25 mg

41780 25 mg
EUR 121.2

Cyanine3 hydrazide, 25 mg

41070 25 mg
EUR 379.2

Cyanine3 maleimide, 25 mg

41080 25 mg
EUR 379.2

Cyanine3 amine, 25 mg

410C0 25 mg
EUR 379.2

MG-132

1703-25
EUR 601.2

MG-115

A2612-25 25 mg
EUR 338.4
Description: MG-115 (Z-Leu-Leu-Nva-H) is a potent, reversible peptide aldehyde inhibitor of proteasome chymotrypsin-like and caspase-like activities. It induces p53 dependent apoptosis. Blockade of proteasomal degradation by MG115 can activate autophagy.

MG-132

A2585-25 25 mg
EUR 226.8
Description: MG132 (carbobenzoxy-Leu-Leu-leucinal) as a peptide aldehyde effectively blocks the proteolytic activity of proteasome complex.9 Proteasome inhibitors including MG132 have been shown to induce apoptotic cell death through formation of ROS.

MG 149

B3276-25 25 mg
EUR 524.4
Description: MG 149 is an inhibitor of histone acetyltransferases (HAT) with IC50 values of 74?M and 47?M for Tip60 and MOF, respectively [1].MG 149 is an anacardic acid derivative.

Sulfo-Cyanine3 azide, 25 mg

D1330 25 mg
EUR 615.6

Sulfo-Cyanine3 alkyne, 25 mg

D13B0 25 mg
EUR 615.6

BDP FL alkyne, 25 mg

D14B0 25 mg
EUR 379.2

BDP FL DBCO, 25 mg

D14F0 25 mg
EUR 379.2

Pyrene azide 1, 25 mg

D1530 25 mg
EUR 379.2

Coumarin 343 azide, 25 mg

D1630 25 mg
EUR 379.2

BDP TMR alkyne, 25 mg

D24B0 25 mg
EUR 379.2

Pyrene azide 2, 25 mg

D2530 25 mg
EUR 379.2

Sulfo-Cyanine5 azide, 25 mg

D3330 25 mg
EUR 615.6

Sulfo-Cyanine5 alkyne, 25 mg

D33B0 25 mg
EUR 615.6

BDP TR alkyne, 25 mg

D34B0 25 mg
EUR 379.2

Biotin PEG3 azide, 25 mg

D3730 25 mg
EUR 116.4

BDP R6G alkyne, 25 mg

D44B0 25 mg
EUR 379.2

BDP R6G DBCO, 25 mg

D44F0 25 mg
EUR 379.2

Sulfo-Cyanine7 azide, 25 mg

D5330 25 mg
EUR 615.6

Sulfo-Cyanine7 alkyne, 25 mg

D53B0 25 mg
EUR 615.6

Sulfo-Cyanine7.5 azide, 25 mg

D6330 25 mg
EUR 615.6

Sulfo-Cyanine7.5 alkyne, 25 mg

D63B0 25 mg
EUR 615.6

Sulfo-Cyanine5.5 azide, 25 mg

D7330 25 mg
EUR 615.6

Sulfo-Cyanine5.5 alkyne, 25 mg

D73B0 25 mg
EUR 615.6

Cyanine5.5 NHS ester, 25 mg

47020 25 mg
EUR 379.2

Cyanine5.5 carboxylic acid, 25 mg

47090 25 mg
EUR 379.2

Sulfo-Cyanine5.5 maleimide, 25 mg

47380 25 mg
EUR 615.6

Sulfo-Cyanine5.5 amine, 25 mg

473C0 25 mg
EUR 615.6

Sulfo-Cyanine7 maleimide, 25 mg

45380 25 mg
EUR 615.6

Sulfo-Cyanine7 amine, 25 mg

453C0 25 mg
EUR 615.6

Cyanine7.5 NHS ester, 25 mg

46020 25 mg
EUR 379.2

Cyanine7.5 carboxylic acid, 25 mg

46090 25 mg
EUR 379.2

sulfo-Cyanine7.5 maleimide, 25 mg

46380 25 mg
EUR 615.6

Cyanine7 NHS ester, 25 mg

45020 25 mg
EUR 379.2

Cyanine7 carboxylic acid, 25 mg

45090 25 mg
EUR 379.2

Cyanine5 NHS ester, 25 mg

43020 25 mg
EUR 379.2

Cyanine5 carboxylic acid, 25 mg

43090 25 mg
EUR 379.2

Cyanine5 Boc-hydrazide, 25 mg

430A0 25 mg
EUR 379.2

Sulfo-Cyanine5 tetrazine, 25 mg

433 25 mg
EUR 615.6

Sulfo-Cyanine5 maleimide, 25 mg

43380 25 mg
EUR 615.6

Sulfo-Cyanine5 amine, 25 mg

433C0 25 mg
EUR 615.6

sulfo-Cyanine5 DBCO, 25 mg

433F0 25 mg
EUR 615.6

BDP TR tetrazine, 25 mg

434 25 mg
EUR 615.6

BDP TR azide, 25 mg

43430 25 mg
EUR 379.2

BDP TR hydrazide, 25 mg

43470 25 mg
EUR 379.2

BDP TR maleimide, 25 mg

43480 25 mg
EUR 379.2

BDP TR amine, 25 mg

434C0 25 mg
EUR 379.2

AF488 NHS ester, 25 mg

41820 25 mg
EUR 615.6

Cyanine3.5 NHS ester, 25 mg

42020 25 mg
EUR 379.2

Cyanine3.5 carboxylic acid, 25 mg

42090 25 mg
EUR 379.2

BDP TMR azide, 25 mg

42430 25 mg
EUR 379.2

BDP TMR maleimide, 25 mg

42480 25 mg
EUR 379.2

BDP TMR amine, 25 mg

424C0 25 mg
EUR 379.2

BDP R6G tetrazine, 25 mg

444 25 mg
EUR 615.6

BDP R6G hydrazide, 25 mg

44470 25 mg
EUR 379.2

BDP R6G maleimide, 25 mg

44480 25 mg
EUR 379.2

BDP R6G amine, 25 mg

444C0 25 mg
EUR 379.2

DBCO NHS ester, 25 mg

44720 25 mg
EUR 121.2

Cyanine3 NHS ester, 25 mg

41020 25 mg
EUR 379.2

Cyanine3 carboxylic acid, 25 mg

41090 25 mg
EUR 379.2

Sulfo-Cyanine3 tetrazine, 25 mg

413 25 mg
EUR 615.6

Sulfo-Cyanine3 maleimide, 25 mg

41380 25 mg
EUR 615.6

Sulfo-Cyanine3 amine, 25 mg

413C0 25 mg
EUR 615.6

sulfo-Cyanine3 DBCO, 25 mg

413F0 25 mg
EUR 615.6

BDP FL tetrazine, 25 mg

414 25 mg
EUR 615.6

BDP FL azide, 25 mg

41430 25 mg
EUR 379.2

BDP FL hydrazide, 25 mg

41470 25 mg
EUR 379.2

BDP FL maleimide, 25 mg

41480 25 mg
EUR 379.2

BDP FL amine, 25 mg

414C0 25 mg
EUR 379.2

BDP R6G azide, 25 mg

1476-25mg 25 mg
EUR 379.2

Cyanine7 dicarboxylic acid, 25 mg

1512-25mg 25 mg
EUR 379.2

CHIR-124

A8394-5 5 mg
EUR 181.2
Description: CHIR-124, a selective inhibitor, inhibits Chk1 with IC50 value of 0.3nM 2,000-fold more potently than Chk2 with IC50 value of 0.7?M.

CHIR-124

A8394-5.1 10 mM (in 1mL DMSO)
EUR 192
Description: CHIR-124, a selective inhibitor, inhibits Chk1 with IC50 value of 0.3nM 2,000-fold more potently than Chk2 with IC50 value of 0.7?M.

CHIR-124

A8394-50 50 mg
EUR 644.4
Description: CHIR-124, a selective inhibitor, inhibits Chk1 with IC50 value of 0.3nM 2,000-fold more potently than Chk2 with IC50 value of 0.7?M.

CHIR-98014

A8395-10 10 mg
EUR 254.4
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1].

CHIR-98014

A8395-5 5 mg
EUR 177.6
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1].

CHIR-98014

A8395-5.1 10 mM (in 1mL DMSO)
EUR 236.4
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1].

CHIR-98014

A8395-50 50 mg
EUR 714
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1].

CHIR-98014

2595-1
EUR 170.4

CHIR-98014

2595-5
EUR 496.8

CHIR-090

A3307-10 10 mg
EUR 458.4
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria.

CHIR-090

A3307-200 200 mg
EUR 3259.2
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria.

CHIR-090

A3307-5 5 mg
EUR 304.8
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria.

CHIR 99021, 25 mg